Trial Profile
A Genotype-Guided Dosing Study of FOLFIRABRAX in Previously Untreated Patients With Advanced Gastrointestinal Malignancies
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 02 Jun 2023
Price :
$35
*
At a glance
- Drugs Paclitaxel (Primary) ; Fluorouracil; Folinic acid; Irinotecan
- Indications Adenocarcinoma; Cholangiocarcinoma; Gallbladder cancer; Gastric cancer; Gastrointestinal cancer; Pancreatic cancer
- Focus Adverse reactions
- 26 May 2023 This study was earlier a phase 1 study, now it has become a phase 2 study.
- 05 Jun 2018 Results presented at the 54th Annual Meeting of the American Society of Clinical Oncology
- 20 Jan 2018 Results presented at the 2018 Gastrointestinal Cancers Symposium